Longboard Pharmaceuticals Inc (LBPH)
21.38
-1.44
(-6.29%)
USD |
NASDAQ |
May 03, 16:00
21.37
0.00 (0.00%)
After-Hours: 20:00
Longboard Pharmaceuticals 1 Year Total Returns (Daily): 159.1% for May 3, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 03, 2024 | 159.1% |
May 02, 2024 | 186.9% |
May 01, 2024 | 184.5% |
April 30, 2024 | 157.2% |
April 29, 2024 | 156.4% |
April 26, 2024 | 159.1% |
April 25, 2024 | 162.3% |
April 24, 2024 | 172.4% |
April 23, 2024 | 179.6% |
April 22, 2024 | 157.5% |
April 19, 2024 | 138.3% |
April 18, 2024 | 155.8% |
April 17, 2024 | 154.5% |
April 16, 2024 | 200.2% |
April 15, 2024 | 200.2% |
April 12, 2024 | 249.7% |
April 11, 2024 | 283.3% |
April 10, 2024 | 265.1% |
April 09, 2024 | 263.6% |
April 08, 2024 | 255.8% |
April 05, 2024 | 300.9% |
April 04, 2024 | 310.9% |
April 03, 2024 | 332.5% |
April 02, 2024 | 393.3% |
April 01, 2024 | 424.9% |
Date | Value |
---|---|
March 28, 2024 | 407.0% |
March 27, 2024 | 394.8% |
March 26, 2024 | 384.6% |
March 25, 2024 | 378.1% |
March 22, 2024 | 369.0% |
March 21, 2024 | 361.2% |
March 20, 2024 | 355.9% |
March 19, 2024 | 436.5% |
March 18, 2024 | 433.3% |
March 15, 2024 | 303.3% |
March 14, 2024 | 307.1% |
March 13, 2024 | 320.2% |
March 12, 2024 | 298.3% |
March 11, 2024 | 312.2% |
March 08, 2024 | 310.4% |
March 07, 2024 | 290.1% |
March 06, 2024 | 264.9% |
March 05, 2024 | 293.3% |
March 04, 2024 | 312.9% |
March 01, 2024 | 285.9% |
February 29, 2024 | 338.3% |
February 28, 2024 | 373.1% |
February 27, 2024 | 366.1% |
February 26, 2024 | 364.2% |
February 23, 2024 | 370.1% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-69.98%
Minimum
Mar 15 2022
669.9%
Maximum
Jan 02 2024
51.64%
Average
13.22%
Median
Dec 08 2023
1 Year Total Returns (Daily) Benchmarks
CEL-SCI Corp | -27.23% |
AIM ImmunoTech Inc | -15.65% |
IGC Pharma Inc | 53.98% |
NovaBay Pharmaceuticals Inc | -90.79% |
Protalix BioTherapeutics Inc | -63.81% |